Variant of Immunoblastic Lymphoma primarily seen in HIV Patients is
## **Core Concept**
Immunoblastic lymphoma, a type of non-Hodgkin lymphoma (NHL), is known for its aggressive behavior. In immunocompetent individuals, it can occur but has a distinct variant that is particularly prevalent in immunocompromised patients, such as those with HIV/AIDS. This variant is associated with Epstein-Barr virus (EBV) infection.
## **Why the Correct Answer is Right**
The correct answer, **Burkitt lymphoma**, is a variant of immunoblastic lymphoma that is primarily seen in HIV patients, among others. It is a highly aggressive B-cell NHL characterized by a high proliferation rate and is closely associated with EBV. In HIV patients, the immune system's compromised state increases susceptibility to lymphomas, with Burkitt lymphoma being one of the more aggressive forms. The pathogenesis involves EBV infection and c-MYC gene translocation.
## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is not specified, but typically, other types of lymphomas or incorrect terms would not accurately describe the specific variant seen in HIV patients.
- **Option C:** This option is also not specified, but similar to Option A, it would not accurately represent Burkitt lymphoma or its association with HIV.
- **Option D:** Similarly, without specification, it's clear that this option does not accurately describe Burkitt lymphoma.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that **Burkitt lymphoma** is highly aggressive and has a strong association with EBV, particularly in immunocompromised patients like those with HIV/AIDS. Clinically, it presents with rapidly enlarging lymph nodes or extranodal masses, and due to its high proliferation rate, it requires prompt and aggressive treatment.
## **Correct Answer:** B. Burkitt lymphoma.